|
|
|
1-10 employees
View all
|
|
Biotechnology
|
|
1000 Atlantic Ave, Suite 104, Alameda, California 94501, US
|
|
Acrigen Biosciences is an early-stage life science gene editing company based in Berkeley, California. We are building a pipeline of therapies to treat genetic disorders using our proprietary precision gene editing technology. Our technology utilizes novel CRISPR-Cas gene editors coupled with anti-CRISPR proteins to improve the precision, efficacy, and safety of genetic therapies. The company was co-founded in 2019 by Dr. Joseph Bondy-Denomy (Associate Professor at UCSF and discoverer of anti-CRISPR proteins) and Dr. David Rabuka (former Founder and CSO of Redwood Biosciences) with the mission of bringing precision genetic therapies to the clinic.
|
Acrigen Biosciences Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Acrigen Biosciences email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Acrigen Biosciences customer service number in your country click here to find.
David R is the CEO of Acrigen Biosciences. To contact David R email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.